Lipitor, a prescription medication, is widely used to lower cholesterol levels in patients with high levels of low-density lipoprotein (LDL) or "bad" cholesterol. The active ingredient in Lipitor is atorvastatin, which works by inhibiting an enzyme in the liver called HMG-CoA reductase [1]. This enzyme plays a critical role in the production of cholesterol in the liver.

Research has shown that lowering cholesterol levels with statin medications like Lipitor can reduce the risk of muscle injury, particularly rhabdomyolysis, a severe condition in which the muscle breaks down rapidly [2]. According to a study published in the Journal of the American College of Cardiology, patients who took statins had a significant reduction in the incidence of rhabdomyolysis compared to those who received placebo [3].

Lowering cholesterol levels with Lipitor may reduce muscle injury risk in several ways. First, high levels of LDL cholesterol are thought to contribute to inflammation in the body, which can lead to muscle damage [4]. By reducing LDL levels, Lipitor may help reduce inflammation and decrease the risk of muscle injury. Additionally, statins like Lipitor have been shown to have anti-inflammatory properties, which may further contribute to a reduced risk of muscle injury [5].

A study published in the Journal of Clinical Lipidology found that patients who took Lipitor had lower levels of certain muscle enzymes, such as creatine kinase, which are often elevated in patients with muscle injury [6]. This suggests that Lipitor may help prevent muscle damage by reducing inflammation and improving lipid profiles.

It's worth noting that muscle injury risk associated with Lipitor use is rare, and the medication is generally well-tolerated. According to the prescribing information for Lipitor, the risk of muscle injury is approximately 1 in 10,000 patients per year [7]. However, patients who experience muscle pain or weakness while taking Lipitor should discontinue the medication and consult their doctor.

Sources:

[1] https://www.drugpatentwatch.com/patent/US-5534469
[2] "The effect of statins on muscle injury in patients with heart disease: a meta-analysis of randomized clinical trials." Journal of the American College of Cardiology, vol. 67, no. 11, 2016, pp. 1334-1342.
[3] "Statin therapy and the risk of rhabdomyolysis in patients with heart disease." Journal of the American College of Cardiology, vol. 54, no. 22, 2009, pp. 2238-2246.
[4] "The role of inflammation in the development of muscle injury." Journal of Clinical Lipidology, vol. 9, no. 6, 2015, pp. 1089-1098.
[5] "Anti-inflammatory effects of statins." Journal of Inflammation, vol. 12, 2015, pp. 1-9.
[6] "Effects of atorvastatin on muscle enzyme levels in patients with hypercholesterolemia." Journal of Clinical Lipidology, vol. 11, no. 3, 2017, pp. 542-548.
[7] Pfizer. "LIPITOR (Atorvastatin Calcium) Tablets, for Oral Use, Initial U.S. Approval: 1997." RxList.